American Vanguard Co. (NYSE:AVD – Get Free Report) has earned an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat.com reports. Four equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among analysts that have issued ratings on the stock in the last year is $16.67.
A number of brokerages have commented on AVD. Loop Capital upped their price target on American Vanguard from $19.00 to $20.00 and gave the stock a “buy” rating in a research report on Monday, April 15th. StockNews.com cut shares of American Vanguard from a “buy” rating to a “hold” rating in a research note on Friday, May 10th. Finally, Lake Street Capital initiated coverage on shares of American Vanguard in a report on Monday, July 22nd. They set a “buy” rating and a $14.00 price target on the stock.
Check Out Our Latest Stock Analysis on AVD
Insiders Place Their Bets
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently modified their holdings of the company. CWM LLC lifted its position in American Vanguard by 492.4% during the fourth quarter. CWM LLC now owns 2,340 shares of the basic materials company’s stock valued at $26,000 after purchasing an additional 1,945 shares during the last quarter. Gladius Capital Management LP bought a new stake in American Vanguard during the fourth quarter worth approximately $37,000. Nisa Investment Advisors LLC raised its position in American Vanguard by 7,554.5% during the second quarter. Nisa Investment Advisors LLC now owns 4,210 shares of the basic materials company’s stock valued at $36,000 after purchasing an additional 4,155 shares during the period. Tower Research Capital LLC TRC lifted its stake in shares of American Vanguard by 240.5% in the 4th quarter. Tower Research Capital LLC TRC now owns 6,885 shares of the basic materials company’s stock valued at $76,000 after purchasing an additional 4,863 shares during the last quarter. Finally, Bfsg LLC bought a new position in shares of American Vanguard during the 4th quarter valued at approximately $98,000. 79.04% of the stock is currently owned by institutional investors.
American Vanguard Stock Performance
AVD opened at $9.56 on Monday. The company’s 50 day moving average is $8.79 and its 200 day moving average is $10.33. The company has a current ratio of 2.29, a quick ratio of 1.12 and a debt-to-equity ratio of 0.50. The company has a market cap of $267.58 million, a price-to-earnings ratio of 36.77 and a beta of 0.91. American Vanguard has a 12-month low of $7.94 and a 12-month high of $18.22.
American Vanguard (NYSE:AVD – Get Free Report) last issued its quarterly earnings results on Thursday, May 9th. The basic materials company reported $0.09 earnings per share for the quarter, topping the consensus estimate of $0.08 by $0.01. The business had revenue of $135.14 million for the quarter, compared to analysts’ expectations of $141.20 million. American Vanguard had a net margin of 1.22% and a return on equity of 2.20%. During the same quarter last year, the company posted $0.07 EPS. On average, equities research analysts predict that American Vanguard will post 0.44 EPS for the current year.
American Vanguard Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 10th. Investors of record on Wednesday, June 26th were paid a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 1.26%. The ex-dividend date was Wednesday, June 26th. American Vanguard’s dividend payout ratio (DPR) is presently 46.15%.
American Vanguard Company Profile
American Vanguard Corporation, through its subsidiaries, develops, manufactures, and markets specialty chemicals for agricultural, commercial, and consumer uses in the United States and internationally. It manufactures and formulates chemicals, including insecticides, fungicides, herbicides, soil health, plant nutrition, molluscicides, growth regulators, soil fumigants, and biorationals in liquid, powder, and granular forms for crops, turf and ornamental plants, and human and animal health protection.
Featured Stories
- Five stocks we like better than American Vanguard
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- 3M Surprises and Rebound Accelerates: It Isn’t Too Late To Get In
- Upcoming IPO Stock Lockup Period, Explained
- Skechers Stock Shows Strength Among Consumer Discretionary Sector
- What is a buyback in stocks? A comprehensive guide for investors
- Tech Stocks Tumble, These Stocks Present Buying Opportunity
Receive News & Ratings for American Vanguard Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Vanguard and related companies with MarketBeat.com's FREE daily email newsletter.